Appropriate Timing of Surgery after Neoadjuvant Chemo-Radiation Therapy for Locally Advanced Rectal Cancer |
Garrer, Waheed Yousry
(Surgical Oncology, National Cancer Institute, Cairo University)
Hossieny, Hisham Abd El Kader El (Radiotherapy, National Cancer Institute, Cairo University) Gad, Zeiad Samir (Surgical Oncology, National Cancer Institute, Cairo University) Namour, Alfred Elias (Medical Oncology departments, National Cancer Institute, Cairo University) Amer, Sameh Mohammed Ahmed Abo (Surgical Oncology, National Cancer Institute, Cairo University) |
1 | Crimaldi A, Huntington CR, Boselli D, et al (2016). Optimal timing of surgical resection after radiationtherapy in locally advanced rectal adenocarcinoma: An analysis of the National Cancer Database. Ann Surg Oncol, 23, 877-87. DOI |
2 | D'Hoore A, Wolthuis AM, Van Cutsem E, et al (2012). Impact of interval between neoadjuvant chemoradiotherapy and TME for locally advanced rectal cancer on pathologic response and oncologic outcome. Ann Surg Oncol, 19, 2833-41. DOI |
3 | da Luz Moreira A, Dietz D, Geisler DP, et al (2011). Neoadjuvant therapy for rectal cancer: the impact of longer interval between chemoradiation and surgery. J Gastrointest Surg, 15, 444-50. DOI |
4 | Feig BW, Crane CH, Eng C, et al (2006). Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer. Am J Clin Oncol, 29, 219-24. DOI |
5 | Fierens K, Pattyn P, Van Nieuwenhove Y, et al (2009). Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer: a systematic review and meta-analysis. Int J Cancer, 124, 2966-72. DOI |
6 | Figer A, Shmueli E, Tulchinsky H, et al (2008). An interval & gt; 7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease free survival in patients with locally advanced rectal cancer. Ann Surg Oncol, 15, 2661-7. DOI |
7 | Figueredo A, Wong RK, De Silva S, et al (2007). Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma. Cochrane Database Syst Rev, 2, 2102. |
8 | Giraudo G, and Morino M (2005). Laparoscopic total mesorectal excision-the Turin experience. Recent Results Cancer Res, 165, 167-79. |
9 | Glimelius B, Pahlman L (1990). Pre-or post operative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicentric trial. Ann Surg, 211, 187-95. DOI |
10 | Gittleman AE, Minsky BD, Wong D, et al (2004). Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resection. Dis Colon Rectum, 47, 279-86. DOI |
11 | Glynne-Jones R, Kerr SF, Norton S (2008). Delaying surgery after neoadjuvant chemoradiotherapy for rectal cancer may reduce postoperative morbidity without compromising prognosis. Br J Surg, 95, 1534-40. DOI |
12 | Gutman H, and Wasserberg N (2008). Resection margins in modern rectal cancer surgery. J Surg Oncol, 98, 611-5. DOI |
13 | Hess CF, Rodel C, Wittekind C, et al (2004). German rectal cancer study group. preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med, 351, 1731-40. DOI |
14 | Hochhaus A, Leitner A, Leitner A, et al (2007). A phase II study of capecitabine and irinotecan in combination with concurrent pelvic radiotherapy (CapIri-RT) as neoadjuvant treatment of locally advanced rectal cancer. Br J Cancer, 96, 912-7. DOI |
15 | Nemoz CJ, Partensky C, Baulieux J, et al (1999). Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol, 17, 2396. DOI |
16 | Holt A, Tran CL, Stamos MJ, et al (2006). Evaluation of safety of increased time interval between chemoradiation and resection for rectal cancer. University of California. Am J Surg, 192, 873-7. DOI |
17 | Kennelly RP, Heeney A, White A, Winter DC, et al (2012). A prospective analysis of patient outcome following treatment of T3 rectal cancer with neo-adjuvant chemoradiotherapy and transanal excision. Int J Colorectal Dis, 27, 759-64. DOI |
18 | Kim DY, Chang HJ, Choi HS, et al (2008). Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers. Ann Surg, 248, 243-51. DOI |
19 | Kulig J, Szura M, Richter P, et al (2012). Randomized clinical trial on preoperative radiotherapy 25 Gy in rectal cancer--treatment results at 5-year follow-up. Langenbecks Arch Surg, 397, 801-7. DOI |
20 | Martling A, Cedermark B, Glimelius B, et al (2015). Tumour regression in the randomized Stockholm III Trial of radiotherapy regimens for rectal cancer. Br J Surg, 102, 972-8. DOI |
21 | Stamm B, Fasolini F, Bouzourene H, et al (2006). Effect of timing of surgery on survival after preoperative hyperfractionated accelerated radiotherapy (HART) for locally advanced rectal cancer (LARC): is it a matter of days? Acta Oncol, 45, 1086-93. DOI |
22 | Rodel C, Calvo FA, Beets GL, et al (2010). Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol, 11, 835-44. DOI |
23 | Serrano A, Pellicer E, Valero G, et al (2003). Neoadjuvant radiation and chemotherapy in rectal cancer does not increase postoperative complications. Int J Colorectal Dis, 18, 495-9. DOI |
24 | Smith DD, Bergsland EK, Garcia-Aguilar J, et al (2011). Optimal timing of surgery after chemoradiation for advanced rectal cancer: preliminary results of a multicenter, nonrandomized phase II prospective trial. Ann Surg, 254, 97-102. DOI |
25 | Volk B, Wolmark N, Peter M (2000). Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum. national surgical adjuvant breast and bowel project protocol R-02. J Natl Cancer Inst, 92, 388-96. DOI |
26 | Buskens CJ, Punt CJ, Geijsen DE, et al (2013). Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer. Br J Surg, 100, 933-9. DOI |
27 | Wibe A, Svensson E, Myrvold HE, et al (2002). Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg, 89, 327-34. DOI |
28 | Allegra CJ, Ursiny CS, Yothers G, et al (2009). Pre-operative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: "NSABP R-03". J Clin Oncol, 27, 5124-30. DOI |
29 | Brown G, Evans J, Patel U (2011). Rectal cancer: primary staging and assessment after chemoradiotherapy. Semin Radiat Oncol, 21, 169-77. DOI |
30 | Buecher B, Bardet E, Rio E, et al (2006). Negative influence of delayed surgery on survival after preoperative radiotherapy in rectal cancer. Colorectal Dis, 8, 430-5. DOI |
31 | Cho CH, Kim H, Roh JK, et al (2006). Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally advanced rectal cancer: Impact of postirradiated pathologic downstaging on local recurrence and survival. Ann Surg, 244, 1024-30. DOI |
32 | Cohen AM, Minsky BD, Chessin DB, et al (2005). Long-term Oncologic Outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer. Ann Surg, 241, 829-38. DOI |
33 | Cooper EJ, Jones EL, Foster JD, et al (2013). Timing of surgery after long-course neoadjuvant chemoradiotherapy for rectal cancer: a systematic review of the literature. Dis Colon Rectum, 56, 921-30. DOI |
![]() |